Epigenetics: spotlight on type 2 diabetes and obesity

J Endocrinol Invest. 2016 Oct;39(10):1095-103. doi: 10.1007/s40618-016-0473-1. Epub 2016 May 14.

Abstract

Type 2 diabetes (T2D) and obesity are the major public health problems. Substantial efforts have been made to define loci and variants contributing to the individual risk of these disorders. However, the overall risk explained by genetic variation is very modest. Epigenetics is one of the fastest growing research areas in biomedicine as changes in the epigenome are involved in many biological processes, impact on the risk for several complex diseases including diabetes and may explain susceptibility. In this review, we focus on the role of DNA methylation in contributing to the risk of T2D and obesity.

Keywords: DNA methylation; Epigenetics; Obesity; Type 2 diabetes.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 2 / genetics*
  • Epigenesis, Genetic / genetics*
  • Humans
  • Obesity / genetics*